Análise de prescrições da terapia medicamentosa e a segurança do paciente em um hospital pediátrico

Abstract

The research aimed to investigate the use of medications in hospitalized children and inadequate prescriptions that may contribute to the occurrence of errors in the medication process. The adopted method consisted of a cross-sectional, retrospective, descriptive and exploratory study conducted at the Children's Hospital of Palmas (HIP) through the analysis of prescriptions of hospitalized children at the time of collection. Data were collected through the instrument consisting of a 27-item checklist and derived from the protocol 'Safety in Prescription, Use and Administration of Medicines' of the National Health Surveillance Agency. Data were organized in Excel® spreadsheets and analyzed using descriptive statistics. The project was approved by the Research Ethics Committee (CAAE 90998318.0.0000.5519). Fifty-four drug prescriptions were analyzed from children, with a mean age of 3.11 years (SD 3.22), who were mostly female (55.56%). The prevalent diagnosis was related to the respiratory system (50%) and the most common reason for hospitalization was pneumonia (88.89%). An average of 7.25 drugs (SD 4.02) per prescription were identified, with a predominance of drugs acting on the nervous system (94.44%). The most commonly used route of administration was intravenous (87.04%) and 16.67% of the prescriptions were considered illegible. The questions that presented the highest number of inadequate answers were Q4, Q7 and Q25, that is, most do not contain the name of the mother or guardian, do not contain information about drug or food allergy, as well as have no speed and time to respond. infusion registered for intravenous medicines. The study identified the existence of inadequate prescriptions for medication in a children's hospital, which may contribute to the occurrence of errors during drug therapy, which reveals the need for training of professionals so that the inconsistencies found are corrected. It is essential that health professionals involved in the medication process recognize the failures found and realize the need for changes to safer child health care.